Shinpoong Pharmaceutical Co (XKRX:019175) Ending Cash Position : ₩41,175 Mil (As of Mar. 2025)

View and export this data going back to 1990. Start your Free Trial

What is Shinpoong Pharmaceutical Co Ending Cash Position?

Shinpoong Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ₩41,175 Mil.

Shinpoong Pharmaceutical Co's quarterly Ending Cash Position declined from Sep. 2024 (₩50,115 Mil) to Dec. 2024 (₩41,986 Mil) and declined from Dec. 2024 (₩41,986 Mil) to Mar. 2025 (₩41,175 Mil).

Shinpoong Pharmaceutical Co's annual Ending Cash Position increased from Dec. 2022 (₩41,691 Mil) to Dec. 2023 (₩43,800 Mil) but then declined from Dec. 2023 (₩43,800 Mil) to Dec. 2024 (₩41,986 Mil).

Shinpoong Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Shinpoong Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shinpoong Pharmaceutical Co Ending Cash Position Chart

Shinpoong Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

55,802.61

27,636.74

41,690.73

43,800.11

41,985.98

Shinpoong Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial															47,300.48	47,951.39	50,114.94	41,985.98	41,174.77

Shinpoong Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Shinpoong Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	43800.114	+	-1814.131
	=	41,986

Shinpoong Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	41985.982	+	-811.21
	=	41,175

Shinpoong Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Shinpoong Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Shinpoong Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shinpoong Pharmaceutical Co Ltd (XKRX:019175) » Definitions » Ending Cash Position

Traded in Other Exchanges

019170:Korea

Address

161, Yeoksam-ro, Gangnam-gu, Seoul, KOR, 06246

Website

https://shinpoong.co.kr

Shinpoong Pharmaceutical Co Ltd specializes in manufacturing remedy drugs and also active pharmaceutical ingredients and finished products. Its products include Newsicam, Caravenal, Roxagen, Clamoxin duo, Ceroxim, and Clocin. The firm's production facilities are located at Gyeonggi-do and Cheongwon-gun.

Shinpoong Pharmaceutical Co Headlines

No Headlines